temptation, page-13

the optimism about this stock hitting all sorts of higher targets whilst nice to think, is getting a bit carried away. the primary drug will, i repeat WILL be involved in a clinical trial, i repeat a TRIAL. IF the results are good then great but let us not forget this is still a trial to be had and sometimes they dont produce the results expected especially for as hardy an adversary as malignancy. I suggest the multi multi bag targets are simply ridiculous at this stage of proceedings and are to be read with a wry smile and perhaps a prayer. This is a trial and results yet to be had.